Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens.

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Electronic cigarette (e-cigarette) flavor restriction policies are associated with reductions in e-cigarette use.

In patients with high-risk OSA, CPAP improves cardiovascular outcomes, while harm may be seen in those with low-risk OSA.

Notable Drug Approvals.

Patients with IA may benefit from HIIT, which was linked to improved cardiorespiratory fitness without worsening disease activity.

There was an increased risk for long COVID among patients with poor asthma control including those with asthma attacks (OR, 1.47; 95% CI, 1.09-1.97) and emergency room (ER) visits for asthma (OR, 1.52 ...

HealthDay News — A Legionnaires’ disease outbreak in Central Harlem has now sickened 90 people and caused three deaths, New York City health officials said Tuesday. The update comes just a few days ...

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.

Never-smokers with lung cancer in high pollution areas have increased TP53 mutations, shorter telomeres, and heightened mutagenesis.